Carcinoid Tumor Syndrome Management Market

Carcinoid tumor syndrome management sales will rise through 2036, driven by small intestine cases at 34.8% of the organ affected segment in 2026. The market was valued at USD 2.27 billion in 2025 and is expected to be worth USD 6.80 billion by 2036, creating an incremental opportunity of USD 4.39 billion.